LU72501A1 - - Google Patents

Info

Publication number
LU72501A1
LU72501A1 LU72501A LU72501A LU72501A1 LU 72501 A1 LU72501 A1 LU 72501A1 LU 72501 A LU72501 A LU 72501A LU 72501 A LU72501 A LU 72501A LU 72501 A1 LU72501 A1 LU 72501A1
Authority
LU
Luxembourg
Application number
LU72501A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2424287A external-priority patent/DE2424287A1/de
Priority claimed from DE19742460333 external-priority patent/DE2460333A1/de
Priority claimed from DE19742460335 external-priority patent/DE2460335A1/de
Application filed filed Critical
Publication of LU72501A1 publication Critical patent/LU72501A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/13—Luteinizing hormone-releasing hormone; related peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
LU72501A 1974-05-18 1975-05-16 LU72501A1 (en:Method)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE2424287A DE2424287A1 (de) 1974-05-18 1974-05-18 Peptide mit lh-rh/fsh-rh-wirkung und verfahren zu ihrer herstellung
DE19742460333 DE2460333A1 (de) 1974-12-20 1974-12-20 Peptide mit lh-rh/fsh-rh-wirkung und verfahren zu ihrer herstellung
DE19742460335 DE2460335A1 (de) 1974-12-20 1974-12-20 Peptide mit lh-rh/fsh-rh-wirkung und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
LU72501A1 true LU72501A1 (en:Method) 1977-02-10

Family

ID=27185941

Family Applications (1)

Application Number Title Priority Date Filing Date
LU72501A LU72501A1 (en:Method) 1974-05-18 1975-05-16

Country Status (11)

Country Link
US (1) US4003884A (en:Method)
JP (1) JPS511469A (en:Method)
CA (1) CA1051873A (en:Method)
CH (1) CH613441A5 (en:Method)
DK (1) DK218175A (en:Method)
FR (1) FR2270890B1 (en:Method)
GB (1) GB1512433A (en:Method)
IE (1) IE41064B1 (en:Method)
IL (1) IL47319A (en:Method)
LU (1) LU72501A1 (en:Method)
NL (1) NL7505590A (en:Method)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2617646C2 (de) * 1976-04-22 1986-07-31 Hoechst Ag, 6230 Frankfurt Nonapeptid-amide und Decapeptid-amide mit Gonadoliberin-Wirkung, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate
DE2905502C2 (de) * 1979-02-14 1982-07-15 Hoechst Ag, 6000 Frankfurt Verfahren zur Herstellung von LH-RH bzw. LH-RH-Analoga und Pyroglutamyl-N↑i↑m↑-dinitrophenyl-histidin
US4256737A (en) * 1979-06-11 1981-03-17 Syntex (U.S.A.) Inc. Long acting depot injectable formulations for LH-RH analogues
FR2465486A1 (fr) * 1979-09-21 1981-03-27 Roussel Uclaf Nouvelle application utilisant la lh-rh ou des agonistes
US4301066A (en) * 1980-05-08 1981-11-17 American Home Products Corp. Preparation of (D-Trp 6)-LH-RH via the heptapeptide H-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH2
DE3020941A1 (de) * 1980-06-03 1981-12-17 Hoechst Ag, 6000 Frankfurt Nonapeptid, verfahren zu seiner herstellung, dieses enthaltendes mittel und seine verwendung
US4443368A (en) * 1982-11-01 1984-04-17 The Salk Institute For Biological Studies Peptides affecting gonadal function
US4410514A (en) * 1982-12-06 1983-10-18 The Salk Institute For Biological Studies GnRH Agonists
HU193607B (en) * 1985-07-18 1987-11-30 Innofinance Altalanos Innovaci Process for production of sexual products applyable for natural or artificial insemination for mammates
EP0882736A1 (en) * 1997-06-02 1998-12-09 Laboratoire Theramex S.A. LH-RH peptide analogues, their uses and pharmaceutical compositions containing them
US20050020524A1 (en) * 1999-04-15 2005-01-27 Monash University Hematopoietic stem cell gene therapy
AUPR074500A0 (en) * 2000-10-13 2000-11-09 Monash University Treatment of t cell disorders
US20040259803A1 (en) * 1999-04-15 2004-12-23 Monash University Disease prevention by reactivation of the thymus
US20070274946A1 (en) * 1999-04-15 2007-11-29 Norwood Immunoloty, Ltd. Tolerance to Graft Prior to Thymic Reactivation
US20040265285A1 (en) * 1999-04-15 2004-12-30 Monash University Normalization of defective T cell responsiveness through manipulation of thymic regeneration
US20040241842A1 (en) * 1999-04-15 2004-12-02 Monash University Stimulation of thymus for vaccination development
US20040258672A1 (en) * 1999-04-15 2004-12-23 Monash University Graft acceptance through manipulation of thymic regeneration
US20060088512A1 (en) * 2001-10-15 2006-04-27 Monash University Treatment of T cell disorders
US20080279812A1 (en) * 2003-12-05 2008-11-13 Norwood Immunology, Ltd. Disease Prevention and Vaccination Prior to Thymic Reactivation
US11793783B2 (en) 2015-08-05 2023-10-24 Cmpd Licensing, Llc Compositions and methods for treating an infection
US11684567B2 (en) 2015-08-05 2023-06-27 Cmpd Licensing, Llc Compositions and methods for treating an infection
US11446236B2 (en) 2015-08-05 2022-09-20 Cmpd Licensing, Llc Topical antimicrobial compositions and methods of formulating the same
US12343345B2 (en) 2018-10-22 2025-07-01 Cmpd Licensing, Llc Non-infective nasal symptom management compositions and methods
US11701426B2 (en) * 2018-10-22 2023-07-18 Cmpd Licensing, Llc Non-infective nasal symptom management compositions and methods

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS528830B2 (en:Method) * 1971-09-02 1977-03-11
US3780014A (en) * 1971-09-16 1973-12-18 Abbott Lab Octapeptide intermediate to gonadotropin releasing hormone
US3790554A (en) * 1971-09-24 1974-02-05 Abbott Lab Heptapeptide intermediate to gonadotropin-releasing hormone
US3835108A (en) * 1972-02-15 1974-09-10 American Home Prod Process for preparing the releasing hormone of luteinizing hormone(lh)and of follicle stimulating hormone(fsh),salts and compositions thereof,and intermediates therefor
US3803117A (en) * 1972-03-24 1974-04-09 Abbott Lab Tetrapeptide
US3888838A (en) * 1972-07-10 1975-06-10 Ayerst Mckenna & Harrison Decapeptide having luteinizing hormone (lh)-and follicle stimulating hormone (fsh)-releasing activity, salts and compositions thereof, a process for preparing same, and intermediates therefor
CA1009230A (en) * 1972-09-26 1977-04-26 Daiichi Seiyaku Co. Peptides effecting to the release of sex hormones and a method for preparing the same
US3826796A (en) * 1972-12-20 1974-07-30 American Home Prod P-glu-his-leu-arg-pro-gly-nh2 and intermediates
US3914412A (en) * 1973-10-11 1975-10-21 Abbott Lab {8 Des{13 Gly{9 {0 10 -Gn{13 RH nonapeptide amide analogs in position 6 having ovulation-inducing activity
US3892723A (en) * 1974-02-04 1975-07-01 American Home Prod P-Glu-Trp-Ser-Tyr-D-Pgl-Leu-Arg-Pro-Gly-NH{HD 2 {B and intermediates
US3901872A (en) * 1974-03-13 1975-08-26 American Home Prod P-glu-his-trp-ser-tyr-d-pgl-leu-arg-pro-gly-nh' 2 'and intermediates

Also Published As

Publication number Publication date
IE41064B1 (en) 1979-10-10
IL47319A0 (en) 1975-07-28
JPS511469A (en:Method) 1976-01-08
IE41064L (en) 1975-11-18
FR2270890A1 (en:Method) 1975-12-12
NL7505590A (nl) 1975-11-20
CH613441A5 (en:Method) 1979-09-28
FR2270890B1 (en:Method) 1980-01-25
CA1051873A (en) 1979-04-03
US4003884A (en) 1977-01-18
IL47319A (en) 1978-06-15
GB1512433A (en) 1978-06-01
DK218175A (da) 1975-11-19

Similar Documents

Publication Publication Date Title
FR2258727B1 (en:Method)
DK139105C (en:Method)
JPS547793B2 (en:Method)
FR2270890B1 (en:Method)
FR2260356B1 (en:Method)
FR2256972A1 (en:Method)
DK95675A (en:Method)
DK540675A (en:Method)
FI752004A7 (en:Method)
FI753433A7 (en:Method)
CS170688B1 (en:Method)
CS173268B1 (en:Method)
DE2402761A1 (en:Method)
CS169480B1 (en:Method)
BG20669A1 (en:Method)
BG19564A1 (en:Method)
CH594154A5 (en:Method)
DD110374A1 (en:Method)
DD110178A1 (en:Method)
BG19956A1 (en:Method)
BG19966A1 (en:Method)
BG20471A1 (en:Method)
CH604152A5 (en:Method)
CH600036A5 (en:Method)
CH597570A5 (en:Method)